| 參考文獻 | Ardlie, N. G., Packham, M. A., and Mustard, J. F. (1970). Adenosine diphosphate-induced platelet aggregation in suspensions of washed rabbit platelets. Br J Haematol 19, 7-17.
Arita, H., Nakano, T., and Hanasaki, K. (1989). Thromboxane A2: its generation and role in platelet activation. Prog Lipid Res 28, 273-301.
Awale, S., Lu, J., Kalauni, S. K., Kurashima, Y., Tezuka, Y., Kadota, S., and Esumi, H. (2006). Identification of arctigenin as an antitumor agent having the ability to eliminate the tolerance of cancer cells to nutrient starvation. Cancer Res 66, 1751-1757.
Baglia, F. A., Badellino, K. O., Li, C. Q., Lopez, J. A., and Walsh, P. N. (2002). Factor XI binding to the platelet glycoprotein Ib-IX-V complex promotes factor XI activation by thrombin. J Biol Chem 277, 1662-1668.
Balsinde, J., Winstead, M. V., and Dennis, E. A. (2002). Phospholipase A2 regulation of arachidonic acid mobilization. FEBS Lett 531, 2-6.
Baluda, V. P., and Lukoianova, T. I. (1985). Arteriovenous difference in antithrombin III activity and the antiaggregation properties of the vessel wall. Biull Eksp Biol Med 99, 263-264.
Banno, Y., Asano, T., and Nozawa, Y. (1998). Stimulation by G protein betagamma subunits of phospholipase C beta isoforms in human platelets. Thromb Haemost 79, 1008-1013.
Barry, O. P., and FitzGerald, G. A. (1999). Mechanisms of cellular activation by platelet microparticles. Thromb Haemost 82, 794-800.
Bennett, J. S. (2001). Novel platelet inhibitors. Annu Rev Med 52, 161-184.
Benveniste, J., Henson, P. M., and Cochrane, C. G. (1972). Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor. J Exp Med 136, 1356-1377.
Bernal-Mizrachi, L., Jy, W., Jimenez, J. J., Pastor, J., Mauro, L. M., Horstman, L. L., de Marchena, E., and Ahn, Y. S. (2003). High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J 145, 962-970.
Berridge, M. J., and Irvine, R. F. (1989). Inositol phosphates and cell signalling. Nature 341, 197-205.
Blockmans, D., Deckmyn, H., and Vermylen, J. (1995). Platelet activation. Blood Rev 9, 143-156.
Born, G. V. (1970). Observations on the change in shape of blood platelets brought about by adenosine diphosphate. J Physiol 209, 487-511.
Braquet, P., Paubert-Braquet, M., Koltai, M., Bourgain, R., Bussolino, F., and Hosford, D. (1989). Is there a case for PAF antagonists in the treatment of ischemic states? Trends Pharmacol Sci 10, 23-30.
Canobbio, I., Balduini, C., and Torti, M. (2004). Signalling through the platelet glycoprotein Ib-V-IX complex. Cell Signal 16, 1329-1344.
Castagna, M., Takai, Y., Kaibuchi, K., Sano, K., Kikkawa, U., and Nishizuka, Y. (1982). Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 257, 7847-7851.
Cattaneo, M. (2005). The P2 receptors and congenital platelet function defects. Semin Thromb Hemost 31, 168-173.
Cepinskas, G., Noseworthy, R., and Kvietys, P. R. (1997). Transendothelial neutrophil migration. Role of neutrophil-derived proteases and relationship to transendothelial protein movement. Circ Res 81, 618-626.
Chandler, W. L., Rodgers, G. M., Sprouse, J. T., and Thompson, A. R. (2002). Elevated hemostatic factor levels as potential risk factors for thrombosis. Arch Pathol Lab Med 126, 1405-1414.
Chao, W., Liu, H., Hanahan, D. J., and Olson, M. S. (1990). Regulation of platelet-activating factor receptor and PAF receptor-mediated arachidonic acid release by protein kinase C activation in rat Kupffer cells. Arch Biochem Biophys 282, 188-197.
Cho, J. Y., Kim, A. R., Yoo, E. S., Baik, K. U., and Park, M. H. (1999). Immunomodulatory effect of arctigenin, a lignan compound, on tumour necrosis factor-alpha and nitric oxide production, and lymphocyte proliferation. J Pharm Pharmacol 51, 1267-1273.
Cho, M. K., Jang, Y. P., Kim, Y. C., and Kim, S. G. (2004). Arctigenin, a phenylpropanoid dibenzylbutyrolactone lignan, inhibits MAP kinases and AP-1 activation via potent MKK inhibition: the role in TNF-alpha inhibition. Int Immunopharmacol 4, 1419-1429.
Cho, M. K., Park, J. W., Jang, Y. P., Kim, Y. C., and Kim, S. G. (2002). Potent inhibition of lipopolysaccharide-inducible nitric oxide synthase expression by dibenzylbutyrolactone lignans through inhibition of I-kappaBalpha phosphorylation and of p65 nuclear translocation in macrophages. Int Immunopharmacol 2, 105-116.
Chow, T. W., Hellums, J. D., Moake, J. L., and Kroll, M. H. (1992). Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation. Blood 80, 113-120.
Ciferri, S., Emiliani, C., Guglielmini, G., Orlacchio, A., Nenci, G. G., and Gresele, P. (2000). Platelets release their lysosomal content in vivo in humans upon activation. Thromb Haemost 83, 157-164.
Cobb, M. H. (1999). MAP kinase pathways. Prog Biophys Mol Biol 71, 479-500.
Cracowski, J. L., Devillier, P., Durand, T., Stanke-Labesque, F., and Bessard, G. (2001). Vascular biology of the isoprostanes. J Vasc Res 38, 93-103.
Cruz, M. A., Chen, J., Whitelock, J. L., Morales, L. D., and Lopez, J. A. (2005). The platelet glycoprotein Ib-von Willebrand factor interaction activates the collagen receptor alpha2beta1 to bind collagen: activation-dependent conformational change of the alpha2-I domain. Blood 105, 1986-1991.
Dorsam, R. T., Kim, S., Jin, J., and Kunapuli, S. P. (2002). Coordinated signaling through both G12/13 and Gi pathways is sufficient to activate GPIIb/IIIa in human platelets. J Biol Chem 277, 47588-47595.
Eckly, A., Gendrault, J. L., Hechler, B., Cazenave, J. P., and Gachet, C. (2001). Differential involvement of the P2Y1 and P2YT receptors in the morphological changes of platelet aggregation. Thromb Haemost 85, 694-701.
Eich, E., Pertz, H., Kaloga, M., Schulz, J., Fesen, M. R., Mazumder, A., and Pommier, Y. (1996). (-)-Arctigenin as a lead structure for inhibitors of human immunodeficiency virus type-1 integrase. J Med Chem 39, 86-95.
Eikelboom, J. W., and Hankey, G. J. (2003). Aspirin resistance: a new independent predictor of vascular events? J Am Coll Cardiol 41, 966-968.
English, D., Garcia, J. G., and Brindley, D. N. (2001). Platelet-released phospholipids link haemostasis and angiogenesis. Cardiovasc Res 49, 588-599.
Ferroni, P., Basili, S., Falco, A., and Davi, G. (2004). Oxidant stress and platelet activation in hypercholesterolemia. Antioxid Redox Signal 6, 747-756.
Fredrickson, B. J., Dong, J. F., McIntire, L. V., and Lopez, J. A. (1998). Shear-dependent rolling on von Willebrand factor of mammalian cells expressing the platelet glycoprotein Ib-IX-V complex. Blood 92, 3684-3693.
Friedman, M., and Van den Bovenkamp, G. J. (1966). The pathogenesis of a coronary thrombus. Am J Pathol 48, 19-44.
Frojmovic, M. M., and Milton, J. G. (1982). Human platelet size, shape, and related functions in health and disease. Physiol Rev 62, 185-261.
Fukuhara, S., Murga, C., Zohar, M., Igishi, T., and Gutkind, J. S. (1999). A novel PDZ domain containing guanine nucleotide exchange factor links heterotrimeric G proteins to Rho. J Biol Chem 274, 5868-5879.
Gailani, D., Fisher, T. C., Mills, D. C., and Macfarlane, D. E. (1990). P47 phosphoprotein of blood platelets (pleckstrin) is a major target for phorbol ester-induced protein phosphorylation in intact platelets, granulocytes, lymphocytes, monocytes and cultured leukaemic cells: absence of P47 in non-haematopoietic cells. Br J Haematol 74, 192-202.
Gear, A. R. (1994). Platelet adhesion, shape change, and aggregation: rapid initiation and signal transduction events. Can J Physiol Pharmacol 72, 285-294.
George, J. N. (2000). Platelets. Lancet 355, 1531-1539.
Gonzalez, E. R. (1998). Antiplatelet therapy in atherosclerotic cardiovascular disease. Clin Ther 20 Suppl B, B18-41.
Grunkemeier, J. M., Tsai, W. B., McFarland, C. D., and Horbett, T. A. (2000). The effect of adsorbed fibrinogen, fibronectin, von Willebrand factor and vitronectin on the procoagulant state of adherent platelets. Biomaterials 21, 2243-2252.
Gurevitz, O., Goldfarb, A., Hod, H., Feldman, M., Shenkman, B., Varon, D., Eldar, M., and Inbal, A. (1998). Recombinant von Willebrand factor fragment AR545C inhibits platelet aggregation and enhances thrombolysis with rtPA in a rabbit thrombosis model. Arterioscler Thromb Vasc Biol 18, 200-207.
Halenda, S. P., Banga, H. S., Zavoico, G. B., Lau, L. F., and Feinstein, M. B. (1989). Synergistic release of arachidonic acid from platelets by activators of protein kinase C and Ca2+ ionophores. Evidence for the role of protein phosphorylation in the activation of phospholipase A2 and independence from the Na+/H+ exchanger. Biochemistry 28, 7356-7363.
Harmon, J. T., and Jamieson, G. A. (1986). The glycocalicin portion of platelet glycoprotein Ib expresses both high and moderate affinity receptor sites for thrombin. A soluble radioreceptor assay for the interaction of thrombin with platelets. J Biol Chem 261, 13224-13229.
Harrison, P., and Cramer, E. M. (1993). Platelet alpha-granules. Blood Rev 7, 52-62.
Hart, M. J., Jiang, X., Kozasa, T., Roscoe, W., Singer, W. D., Gilman, A. G., Sternweis, P. C., and Bollag, G. (1998). Direct stimulation of the guanine nucleotide exchange activity of p115 RhoGEF by Galpha13. Science 280, 2112-2114.
Hartwig, J. H. (1992). Mechanisms of actin rearrangements mediating platelet activation. J Cell Biol 118, 1421-1442.
Hers, I., Donath, J., van Willigen, G., and Akkerman, J. W. (1998). Differential involvement of tyrosine and serine/threonine kinases in platelet integrin alphaIIbbeta3 exposure. Arterioscler Thromb Vasc Biol 18, 404-414.
Hewett, J. A., and Roth, R. A. (1993). Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides. Pharmacol Rev 45, 382-411.
Hirsch, E., Bosco, O., Tropel, P., Laffargue, M., Calvez, R., Altruda, F., Wymann, M., and Montrucchio, G. (2001). Resistance to thromboembolism in PI3Kgamma-deficient mice. Faseb J 15, 2019-2021.
Hoffman, M., and Monroe, D. M., 3rd (2001). A cell-based model of hemostasis. Thromb Haemost 85, 958-965.
Hoots, W. K. (2002). Non-overt disseminated intravascular coagulation: definition and pathophysiological implications. Blood Rev 16 Suppl 1, S3-9.
Hung, D. T., Wong, Y. H., Vu, T. K., and Coughlin, S. R. (1992). The cloned platelet thrombin receptor couples to at least two distinct effectors to stimulate phosphoinositide hydrolysis and inhibit adenylyl cyclase. J Biol Chem 267, 20831-20834.
Huo, Y., Schober, A., Forlow, S. B., Smith, D. F., Hyman, M. C., Jung, S., Littman, D. R., Weber, C., and Ley, K. (2003). Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 9, 61-67.
Hynes, R. O. (1992). Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69, 11-25.
Iwakami, S., Wu, J. B., Ebizuka, Y., and Sankawa, U. (1992). Platelet activating factor (PAF) antagonists contained in medicinal plants: lignans and sesquiterpenes. Chem Pharm Bull (Tokyo) 40, 1196-1198.
Jaken, S., and Parker, P. J. (2000). Protein kinase C binding partners. Bioessays 22, 245-254.
Jang, Y. P., Kim, S. R., Choi, Y. H., Kim, J., Kim, S. G., Markelonis, G. J., Oh, T. H., and Kim, Y. C. (2002). Arctigenin protects cultured cortical neurons from glutamate-induced neurodegeneration by binding to kainate receptor. J Neurosci Res 68, 233-240.
Jang, Y. P., Kim, S. R., and Kim, Y. C. (2001). Neuroprotective dibenzylbutyrolactone lignans of Torreya nucifera. Planta Med 67, 470-472.
Jorgensen, L. (1964). Experimental platelet and coagulation thrombi. A histological study of arterial and venous thrombi of varying age in untreated and heparinized rabbits. Acta Pathol Microbiol Scand 62, 189-223.
Jorgensen, L., and Torvik, A. (1966). Ischaemic cerebrovascular diseases in an autopsy series. I. Prevalence, location and predisposing factors in verified thrombo-embolic occlusions, and their significance in the pathogenesis of cerebral infarction. J Neurol Sci 3, 490-509.
Kahn, M. L., Nakanishi-Matsui, M., Shapiro, M. J., Ishihara, H., and Coughlin, S. R. (1999). Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest 103, 879-887.
Kaibuchi, K., Takai, Y., Sawamura, M., Hoshijima, M., Fujikura, T., and Nishizuka, Y. (1983). Synergistic functions of protein phosphorylation and calcium mobilization in platelet activation. J Biol Chem 258, 6701-6704.
Kao, S., and McIntire, L. V. (2003). Rheology, in Thrombosis and Hemorrhange, 3rd edn (Philadelphis: Lippincott Williams and Wilkins).
Karim, S., Habib, A., Levy-Toledano, S., and Maclouf, J. (1996). Cyclooxygenase-1 and -2 of endothelial cells utilize exogenous or endogenous arachidonic acid for transcellular production of thromboxane. J Biol Chem 271, 12042-12048.
Kasirer-Friede, A., Cozzi, M. R., Mazzucato, M., De Marco, L., Ruggeri, Z. M., and Shattil, S. J. (2004). Signaling through GP Ib-IX-V activates alpha IIb beta 3 independently of other receptors. Blood 103, 3403-3411.
Knupp, C. L., and White, G. C., 2nd (1984). The effect of platelet inhibitors on glycoprotein V hydrolysis by thrombin. Thromb Res 34, 225-231.
Kroll, M. H., Hellums, J. D., Guo, Z., Durante, W., Razdan, K., Hrbolich, J. K., and Schafer, A. I. (1993). Protein kinase C is activated in platelets subjected to pathological shear stress. J Biol Chem 268, 3520-3524.
Kroll, M. H., Hellums, J. D., McIntire, L. V., Schafer, A. I., and Moake, J. L. (1996). Platelets and shear stress. Blood 88, 1525-1541.
Kubes, P., and McCafferty, D. M. (2000). Nitric oxide and intestinal inflammation. Am J Med 109, 150-158.
Kurantsin-Mills, J., Ibe, B. O., Natta, C. L., Raj, J. U., Siegel, R. S., and Lessin, L. S. (1994). Elevated urinary levels of thromboxane and prostacyclin metabolities in sickle cell disease reflects activated platelets in the circulation. Br J Haematol 87, 580-585.
Lee, Y. J., Jy, W., Horstman, L. L., Janania, J., Reyes, Y., Kelley, R. E., and Ahn, Y. S. (1993). Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. Thromb Res 72, 295-304.
Levy-Toledano, S. (1999). Platelet signal transduction pathways: could we organize them into a 'hierarchy'? Haemostasis 29, 4-15.
Lewis, T. S., Shapiro, P. S., and Ahn, N. G. (1998). Signal transduction through MAP kinase cascades. Adv Cancer Res 74, 49-139.
Li, Z., Zhang, G., Le Breton, G. C., Gao, X., Malik, A. B., and Du, X. (2003). Two waves of platelet secretion induced by thromboxane A2 receptor and a critical role for phosphoinositide 3-kinases. J Biol Chem 278, 30725-30731.
Lokeshwar, V. B., and Bourguignon, L. Y. (1992). The involvement of Ca2+ and myosin light chain kinase in collagen-induced platelet activation. Cell Biol Int Rep 16, 883-897.
Lopez, J. A. (1994). The platelet glycoprotein Ib-IX complex. Blood Coagul Fibrinolysis 5, 97-119.
Massberg, S., Brand, K., Gruner, S., Page, S., Muller, E., Muller, I., Bergmeier, W., Richter, T., Lorenz, M., Konrad, I., Nieswandt, B., Gawaz, M. (2002). A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 196, 887-896.
Mazzucato, M., Cozzi, M. R., Pradella, P., Ruggeri, Z. M., and De Marco, L. (2004). Distinct roles of ADP receptors in von Willebrand factor-mediated platelet signaling and activation under high flow. Blood 104, 3221-3227.
McNicol, A., and Jackson, E. C. (2003). Inhibition of the MEK/ERK pathway has no effect on agonist-induced aggregation of human platelets. Biochem Pharmacol 65, 1243-1250.
McNicol, A., Shibou, T. S., Pampolina, C., and Israels, S. J. (2001). Incorporation of map kinases into the platelet cytoskeleton. Thromb Res 103, 25-34.
Merritt, J. E., McCarthy, S. A., Davies, M. P., and Moores, K. E. (1990). Use of fluo-3 to measure cytosolic Ca2+ in platelets and neutrophils. Loading cells with the dye, calibration of traces, measurements in the presence of plasma, and buffering of cytosolic Ca2+. Biochem J 269, 513-519.
Monroe, D. M., Hoffman, M., and Roberts, H. R. (2002). Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 22, 1381-1389.
Montrucchio, G., Alloatti, G., and Camussi, G. (2000). Role of platelet-activating factor in cardiovascular pathophysiology. Physiol Rev 80, 1669-1699.
Moritani, S., Nomura, M., Takeda, Y., and Miyamoto, K. (1996). Cytotoxic components of Bardanae fructus (goboshi). Biol Pharm Bull 19, 1515-1517.
Morrow, J. D., Hill, K. E., Burk, R. F., Nammour, T. M., Badr, K. F., and Roberts, L. J., 2nd (1990). A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 87, 9383-9387.
Mousa, S. A. (1999). Antiplatelet therapies: from aspirin to GPIIb/IIIa-receptor antagonists and beyond. Drug Discov Today 4, 552-561.
Nachmias, V. T., Kavaler, J., and Jacubowitz, S. (1985). Reversible association of myosin with the platelet cytoskeleton. Nature 313, 70-72.
Nakashima, S., Chatani, Y., Nakamura, M., Miyoshi, N., Kohno, M., and Nozawa, Y. (1994). Tyrosine phosphorylation and activation of mitogen-activated protein kinases by thrombin in human platelets: possible involvement in late arachidonic acid release. Biochem Biophys Res Commun 198, 497-503.
Nishibori, M., Cham, B., McNicol, A., Shalev, A., Jain, N., and Gerrard, J. M. (1993). The protein CD63 is in platelet dense granules, is deficient in a patient with Hermansky-Pudlak syndrome, and appears identical to granulophysin. J Clin Invest 91, 1775-1782.
Offermanns, S. (2000). The role of heterotrimeric G proteins in platelet activation. Biol Chem 381, 389-396.
Offermanns, S. (2003). G-proteins as transducers in transmembrane signalling. Prog Biophys Mol Biol 83, 101-130.
Offermanns, S., Laugwitz, K. L., Spicher, K., and Schultz, G. (1994). G proteins of the G12 family are activated via thromboxane A2 and thrombin receptors in human platelets. Proc Natl Acad Sci USA 91, 504-508.
Oury, C., Toth-Zsamboki, E., Thys, C., Tytgat, J., Vermylen, J., and Hoylaerts, M. F. (2001). The ATP-gated P2X1 ion channel acts as a positive regulator of platelet responses to collagen. Thromb Haemost 86, 1264-1271.
Papkoff, J., Chen, R. H., Blenis, J., and Forsman, J. (1994). p42 mitogen-activated protein kinase and p90 ribosomal S6 kinase are selectively phosphorylated and activated during thrombin-induced platelet activation and aggregation. Mol Cell Biol 14, 463-472.
Patrignani, P., and Tacconelli, S. (2005). Isoprostanes and other markers of peroxidation in atherosclerosis. Biomarkers 10 Suppl 1, S24-29.
Paul, B. Z., Jin, J., and Kunapuli, S. P. (1999). Molecular mechanism of thromboxane A2-induced platelet aggregation. Essential role for p2t(ac) and alpha(2a) receptors. J Biol Chem 274, 29108-29114.
Peerschke, E. I. (1992). Platelet membrane glycoproteins. Functional characterization and clinical applications. Am J Clin Pathol 98, 455-463.
Peerschke, E. I. (1995). Regulation of platelet aggregation by post-fibrinogen binding events. Insights provided by dithiothreitol-treated platelets. Thromb Haemost 73, 862-867.
Philip, F., Guo, Y., and Scarlata, S. (2002). Multiple roles of pleckstrin homology domains in phospholipase Cb function. FEBS Lett 531, 28-32.
Putney, J. W., Jr. (1986). A model for receptor-regulated calcium entry. Cell Calcium 7, 1-12.
Quinton, T. M., Murugappan, S., Kim, S., Jin, J., and Kunapuli, S. P. (2004). Different G protein-coupled signaling pathways are involved in alpha granule release from human platelets. J Thromb Haemost 2, 978-984.
Rabie, T., Strehl, A., Ludwig, A., and Nieswandt, B. (2005). Evidence for a role of ADAM17 (TACE) in the regulation of platelet glycoprotein V. J Biol Chem 280, 14462-14468.
Razdan, K., Hellums, J. D., and Kroll, M. H. (1994). Shear-stress-induced von Willebrand factor binding to platelets causes the activation of tyrosine kinase(s). Biochem J 302 (Pt 3), 681-686.
Rink, T. J., and Sage, S. O. (1990). Calcium signaling in human platelets. Annu Rev Physiol 52, 431-449.
Rittenhouse, S. E. (1996). Phosphoinositide 3-kinase activation and platelet function. Blood 88, 4401-4414.
Rosado, J. A., and Sage, S. O. (2000). Phosphoinositides are required for store-mediated calcium entry in human platelets. J Biol Chem 275, 9110-9113.
Rosado, J. A., and Sage, S. O. (2001). Role of the ERK pathway in the activation of store-mediated calcium entry in human platelets. J Biol Chem 276, 15659-15665.
Ruggeri, Z. M., Dent, J. A., and Saldivar, E. (1999). Contribution of distinct adhesive interactions to platelet aggregation in flowing blood. Blood 94, 172-178.
Sage, S. O. (1997). The Wellcome Prize Lecture. Calcium entry mechanisms in human platelets. Exp Physiol 82, 807-823.
Sage, S. O., Brownlow, S. L., and Rosado, J. A. (2002). TRP channels and calcium entry in human platelets. Blood 100, 4245-4246; author reply 4246-4247.
Savage, B., Almus-Jacobs, F., and Ruggeri, Z. M. (1998). Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell 94, 657-666.
Savage, B., Ginsberg, M. H., and Ruggeri, Z. M. (1999). Influence of fibrillar collagen structure on the mechanisms of platelet thrombus formation under flow. Blood 94, 2704-2715.
Savage, B., Saldivar, E., and Ruggeri, Z. M. (1996). Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 84, 289-297.
Schmidt, V. A., Nierman, W. C., Maglott, D. R., Cupit, L. D., Moskowitz, K. A., Wainer, J. A., and Bahou, W. F. (1998). The human proteinase-activated receptor-3 (PAR-3) gene. Identification within a Par gene cluster and characterization in vascular endothelial cells and platelets. J Biol Chem 273, 15061-15068.
Schroder, H. C., Merz, H., Steffen, R., Muller, W. E., Sarin, P. S., Trumm, S., Schulz, J., and Eich, E. (1990). Differential in vitro anti-HIV activity of natural lignans. Z Naturforsch [C] 45, 1215-1221.
Shah, B. H., Rasheed, H., Rahman, I. H., Shariff, A. H., Khan, F. L., Rahman, H. B., Hanif, S., and Saeed, S. A. (2001). Molecular mechanisms involved in human platelet aggregation by synergistic interaction of platelet-activating factor and 5-hydroxytryptamine. Exp Mol Med 33, 226-233.
Shattil, S. J., Kashiwagi, H., and Pampori, N. (1998). Integrin signaling: the platelet paradigm. Blood 91, 2645-2657.
Shouzu, A., Nomura, S., Omoto, S., Hayakawa, T., Nishikawa, M., and Iwasaka, T. (2004). Effect of ticlopidine on monocyte-derived microparticles and activated platelet markers in diabetes mellitus. Clin Appl Thromb Hemost 10, 167-173.
Siess, W., and Lapetina, E. G. (1988). Ca2+ mobilization primes protein kinase C in human platelets. Ca2+ and phorbol esters stimulate platelet aggregation and secretion synergistically through protein kinase C. Biochem J 255, 309-318.
Siljander, P., and Lassila, R. (1999). Studies of adhesion-dependent platelet activation: distinct roles for different participating receptors can be dissociated by proteolysis of collagen. Arterioscler Thromb Vasc Biol 19, 3033-3043.
Silver, M. J., Sutton, J. M., Hook, S., Lee, P., Malycky, J. L., Phillips, M. L., Ellis, S. G., Topol, E. J., and Nicolini, F. A. (1995). Adjunctive selectin blockade successfully reduces infarct size beyond thrombolysis in the electrolytic canine coronary artery model. Circulation 92, 492-499.
Siminiak, T., Egdell, R. M., O'Gorman, D. J., Dye, J. F., and Sheridan, D. J. (1995). Plasma-mediated neutrophil activation during acute myocardial infarction: role of platelet-activating factor. Clin Sci (Lond) 89, 171-176.
Suzuki, N., Nakamura, S., Mano, H., and Kozasa, T. (2003). Galpha 12 activates Rho GTPase through tyrosine-phosphorylated leukemia-associated RhoGEF. Proc Natl Acad Sci U S A 100, 733-738.
Takaaki, H., Ginsberg, M. H., and Shattil, S. J. (2002). Integrin aIIbb3 in Platelets (San Diego, California), pp. 105-116.
Takahashi, K., Nammour, T. M., Fukunaga, M., Ebert, J., Morrow, J. D., Roberts, L. J., 2nd, Hoover, R. L., and Badr, K. F. (1992). Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors. J Clin Invest 90, 136-141.
Tan, K. T., and Lip, G. Y. (2003). Red vs white thrombi: treating the right clot is crucial. Arch Intern Med 163, 2534-2535; author reply 2535.
Tan, K. T., and Lip, G. Y. (2005). The assessment of platelet activation in antiplatelet drug development. Curr Med Chem 12, 3117-3125.
Tan, K. T., Lip, G. Y., and Blann, A. D. (2003). Post-stroke inflammatory response: effects of stroke evolution and outcome. Curr Atheroscler Rep 5, 245-251.
Tan, K. T., Tayebjee, M. H., Lynd, C., Blann, A. D., and Lip, G. Y. (2005). Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers. Ann Med 37, 61-66.
Turner, N. A., Moake, J. L., and McIntire, L. V. (2001). Blockade of adenosine diphosphate receptors P2Y12 and P2Y1 is required to inhibit platelet aggregation in whole blood under flow. Blood 98, 3340-3345.
Umehara, K., Nakamura, M., Miyase, T., Kuroyanagi, M., and Ueno, A. (1996). Studies on differentiation inducers. VI. Lignan derivatives from Arctium fructus. (2). Chem Pharm Bull (Tokyo) 44, 2300-2304.
Verstraete, M., Dejana, E., Fuster, V., Lapetina, E., Moncada, S., Mustard, J. F., Tans, G., and Vargaftig, B. B. (1985). An overview of antiplatelet and antithrombotic drugs. Haemostasis 15, 89-99.
Vincent, J. L., Yagushi, A., and Pradier, O. (2002). Platelet function in sepsis. Crit Care Med 30, S313-317.
Vu, T. K., Hung, D. T., Wheaton, V. I., and Coughlin, S. R. (1991). Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64, 1057-1068.
Walker, T. R., and Watson, S. P. (1993). Synergy between Ca2+ and protein kinase C is the major factor in determining the level of secretion from human platelets. Biochem J 289 (Pt 1), 277-282.
Watson, W. H., Zhao, Y., and Chawla, R. K. (1999). S-adenosylmethionine attenuates the lipopolysaccharide-induced expression of the gene for tumour necrosis factor alpha. Biochem J 342 (Pt 1), 21-25.
Weyrich, A. S., Lindemann, S., and Zimmerman, G. A. (2003). The evolving role of platelets in inflammation. J Thromb Haemost 1, 1897-1905.
Whatley, R. E., Zimmerman, G. A., McIntyre, T. M., Taylor, R., and Prescott, S. M. (1987). Production of platelet-activating factor by endothelial cells. Semin Thromb Hemost 13, 445-453.
White, J. G., Colman, R. W., Hirsh, J., Marder, V. J., and Salzman, E. W. (1994). Anatomy and structural organization of the platelet. In Hemostasis and thrombosis: Basic principles and clinical practice, 3rd edn (Philadelphia: J.B. Lippincott Company). 397-413.
Wilcox, D. A., and White, G. C., 2nd (2003). Gene therapy for platelet disorders: studies with Glanzmann's thrombasthenia. J Thromb Haemost 1, 2300-2311.
Woulfe, D., Yang, J., Prevost, N., O'Brien, P. J., and Brass, L. F. (2002). Signal transduction during the initiation, extension, and perpetuation of platelet plug formation, in Platelets (San Diego, California), pp. 197-213.
Wu, D., Meiring, M., Kotze, H. F., Deckmyn, H., and Cauwenberghs, N. (2002). Inhibition of platelet glycoprotein Ib, glycoprotein IIb/IIIa, or both by monoclonal antibodies prevents arterial thrombosis in baboons. Arterioscler Thromb Vasc Biol 22, 323-328.
Wykle, R. L., Malone, B., and Snyder, F. (1980). Enzymatic synthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine, a hypotensive and platelet-aggregating lipid. J Biol Chem 255, 10256-10260.
Yagi, K. (1998). Simple assay for the level of total lipid peroxides in serum or plasma. Methods Mol Biol 108, 101-106.
Yang, Z., Liu, N., Huang, B., Wang, Y., Hu, Y., and Zhu, Y. (2005). Effect of anti-influenza virus of Arctigenin in vivo. Zhong Yao Cai 28, 1012-1014.
|
|---|
